Sanjaya K Satapathy1, Jason M Vanatta, Ryan A Helmick, Albert Flowers, Satish K Kedia, Yu Jiang, Bilal Ali, James Eason, Satheesh P Nair, Uzoma N Ibebuogu. 1. 1 Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN. 2 Department of Internal Medicine, University of Tennessee Health Sciences Center, Memphis, TN. 3 School of Public Health, University of Memphis, Memphis, TN. 4 Department of Cardiology, Methodist University Hospital, University of Tennessee Health Sciences Center, Memphis, TN.
Abstract
BACKGROUND: Coronary artery disease (CAD) is a significant problem during evaluation for liver transplantation (LT). We aim to assess survival in LT recipients based on presence, severity, extent of CAD, and cardiac events within 90 days of LT. METHODS: Eighty-seven LT recipients with history of pre-LT angiogram (December 2005 to December 2012) were compared with 2 control groups without prior angiogram, 72 LT recipients matched for cardiovascular risk factors (control group I), and 119 consecutive LT recipients without any CV risk factors (control group II). CAD was assessed by (1) vessel score (≥50% reduction in luminal diameter), and (2) Extent score (Reardon scoring system). RESULTS: Of the 87 LT recipients (study group), 58 (66.7%) had none or less than 50% stenosis, 29 (33.3%) had obstructive CAD (≥50% stenosis), 7 (8%) with single-vessel disease, and 22 (25.3%) with multivessel disease. In the study group, irrespective of prerevascularization severity of CAD (P = 0.357), number of segments involved (0, 1-2, > 2 segments, P = 0.304) and extent of CAD based on Reardon score (0, 1-9, >10, P = 0.224), comparable posttransplant survival was noted. Overall, patient survival in the revascularized CAD group was comparable to angiogram group without obstructive CAD, and both control group I and control group II (P = 0.184, Log Rank). Postoperative cardiac events within 90 days of LT predicted poor survival in study group as well as control groups. CONCLUSIONS: Severity or extent of CAD does not impact post-LT survival, if appropriately revascularized. Early postoperative cardiac events are associated with inferior survival in LT recipients, irrespective of underlying CAD.
BACKGROUND:Coronary artery disease (CAD) is a significant problem during evaluation for liver transplantation (LT). We aim to assess survival in LT recipients based on presence, severity, extent of CAD, and cardiac events within 90 days of LT. METHODS: Eighty-seven LT recipients with history of pre-LT angiogram (December 2005 to December 2012) were compared with 2 control groups without prior angiogram, 72 LT recipients matched for cardiovascular risk factors (control group I), and 119 consecutive LT recipients without any CV risk factors (control group II). CAD was assessed by (1) vessel score (≥50% reduction in luminal diameter), and (2) Extent score (Reardon scoring system). RESULTS: Of the 87 LT recipients (study group), 58 (66.7%) had none or less than 50% stenosis, 29 (33.3%) had obstructive CAD (≥50% stenosis), 7 (8%) with single-vessel disease, and 22 (25.3%) with multivessel disease. In the study group, irrespective of prerevascularization severity of CAD (P = 0.357), number of segments involved (0, 1-2, > 2 segments, P = 0.304) and extent of CAD based on Reardon score (0, 1-9, >10, P = 0.224), comparable posttransplant survival was noted. Overall, patient survival in the revascularized CAD group was comparable to angiogram group without obstructive CAD, and both control group I and control group II (P = 0.184, Log Rank). Postoperative cardiac events within 90 days of LT predicted poor survival in study group as well as control groups. CONCLUSIONS: Severity or extent of CAD does not impact post-LT survival, if appropriately revascularized. Early postoperative cardiac events are associated with inferior survival in LT recipients, irrespective of underlying CAD.
Authors: Charles J Davidson; Mihai Gheorghiade; James D Flaherty; Michael D Elliot; Srinivas P Reddy; Norman C Wang; Sri A Sundaram; Steven L Flamm; Andres T Blei; Michael I Abecassis; Robert O Bonow Journal: Am J Cardiol Date: 2002-02-01 Impact factor: 2.778
Authors: Haripriya Maddur; Patrick D Bourdillon; Suthat Liangpunsakul; A Joseph Tector; Jonathan A Fridell; Marwan Ghabril; Marco A Lacerda; Charlotte Bourdillon; Changyu Shen; Paul Y Kwo Journal: Liver Transpl Date: 2014-06 Impact factor: 5.799
Authors: Lisa B Vanwagner; Manali Bhave; Helen S Te; Joe Feinglass; Lisa Alvarez; Mary E Rinella Journal: Hepatology Date: 2012-11 Impact factor: 17.425
Authors: M E Harinstein; J D Flaherty; A H Ansari; J Robin; C J Davidson; J S Rossi; S L Flamm; A T Blei; R O Bonow; M Abecassis; M Gheorghiade Journal: Am J Transplant Date: 2008-07 Impact factor: 8.086
Authors: Jeane M Tsutsui; Sandeep Mukherjee; Abdou Elhendy; Feng Xie; Elizabeth R Lyden; Edward O'Leary; Anna C McGrain; Thomas R Porter Journal: Liver Transpl Date: 2006-04 Impact factor: 5.799
Authors: A Aydinalp; U Bal; I Atar; C Ertan; A Aktaş; A Yildirir; B Ozin; H Mudderisoglu; M Haberal Journal: Transplant Proc Date: 2009-11 Impact factor: 1.066
Authors: Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar Journal: Hepatol Int Date: 2016-06-16 Impact factor: 6.047
Authors: C L Donovan; P A Marcovitz; J D Punch; D S Bach; K A Brown; M R Lucey; W F Armstrong Journal: Transplantation Date: 1996-04-27 Impact factor: 4.939
Authors: Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui Journal: Liver Int Date: 2019-03-26 Impact factor: 5.828
Authors: Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel Journal: Am J Transplant Date: 2017-11-18 Impact factor: 8.086
Authors: Eva Montalvá; Manuel Rodríguez-Perálvarez; Annabel Blasi; Santiago Bonanad; Olga Gavín; Loreto Hierro; Laura Lladó; Elba Llop; Juan Carlos Pozo-Laderas; Jordi Colmenero Journal: Transplantation Date: 2022-01-04 Impact factor: 5.385